Cite
Zhang Y, Ren P, Kang Q, et al. Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE. Evid Based Complement Alternat Med. 2017;2017:3121989doi: 10.1155/2017/3121989.
Zhang, Y., Ren, P., Kang, Q., Liu, W., Li, S., Li, P., Liu, H., Shang, J., Zhang, L., Gong, Y., & Zhou, M. (2017). Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE. Evidence-based complementary and alternative medicine : eCAM, 20173121989. https://doi.org/10.1155/2017/3121989
Zhang, Ying, et al. "Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE." Evidence-based complementary and alternative medicine : eCAM vol. 2017 (2017): 3121989. doi: https://doi.org/10.1155/2017/3121989
Zhang Y, Ren P, Kang Q, Liu W, Li S, Li P, Liu H, Shang J, Zhang L, Gong Y, Zhou M. Effect of Tetramethylpyrazine on Atherosclerosis and SCAP/SREBP-1c Signaling Pathway in ApoE. Evid Based Complement Alternat Med. 2017;2017:3121989. doi: 10.1155/2017/3121989. Epub 2017 Apr 12. PMID: 28491104; PMCID: PMC5405370.
Copy
Download .nbib